Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Boattini

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
The Journal of Antimicrobial Chemotherapy|June 8, 2026
Evaluation of in vitro synergy of cefepime/enmetazobactam combined with aztreonam against metallo-β-lactamase-producing EnterobacteralesMatteo Boattini, Alessandra Cornacchia, Sara Comini, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Disc Diffusion and ComASP<sup>®</sup> Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory RoutineGabriele Bianco, Matteo Boattini, Sara Comini, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2022
Increased <i>bla</i><sub>KPC</sub> Copy Number and OmpK35 and OmpK36 Porins Disruption Mediated Resistance to Imipenem/Relebactam and Meropenem/Vaborbactam in a KPC-Producing Klebsiella pneumoniae Clinical IsolatePaolo Gaibani, Gabriele Bianco, Stefano Amadesi, et al.
Journal of Chemotherapy (Florence, Italy)|April 12, 2021
Looking beyond ceftazidime-avibactam resistance in KPC-producing <i>Klebsiella pneumoniae</i>: <i>in vitro</i> activity of the novel meropenem-vaborbactam in combination with the old fosfomycinMatteo Boattini, Gabriele Bianco, Marco Iannaccone, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 11, 2025
In vitro activity and resistance mechanisms of novel antimicrobial agents against metallo-β-lactamase producersMatteo Boattini, Paolo Gaibani, Sara Comini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 31, 2021
In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effectsGabriele Bianco, Matteo Boattini, Sara Comini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 21, 2022
Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 eraGabriele Bianco, Matteo Boattini, Sara Comini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 18, 2021
Fast-track identification of CTX-M-extended-spectrum-β-lactamase- and carbapenemase-producing Enterobacterales in bloodstream infections: implications on the likelihood of deduction of antibiotic susceptibility in emergency and internal medicine departmentsMatteo Boattini, Gabriele Bianco, Marco Iannaccone, et al.
Pathogens (Basel, Switzerland)|June 26, 2024
Complete Genome Sequence of a <i>Klebsiella pneumoniae</i> Strain Carrying Novel Variant <i>bla</i><sub>KPC-203</sub>, Cross-Resistant to Ceftazidime/Avibactam and Cefiderocol, but Susceptible to Carbapenems, Isolated in Italy, 2023Stefano Amadesi, Gabriele Bianco, Benedetta Secci, et al.
Microorganisms|January 21, 2023
MALDI-TOF MS-Based Approaches for Direct Identification of Gram-Negative Bacteria and <i>Bla</i><sub>KPC</sub>-Carrying Plasmid Detection from Blood Cultures: A Three-Year Single-Centre Study and Proposal of a Diagnostic AlgorithmGabriele Bianco, Sara Comini, Matteo Boattini, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|June 8, 2026
Evaluation of in vitro synergy of cefepime/enmetazobactam combined with aztreonam against metallo-β-lactamase-producing EnterobacteralesMatteo Boattini, Alessandra Cornacchia, Sara Comini, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Disc Diffusion and ComASP<sup>®</sup> Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory RoutineGabriele Bianco, Matteo Boattini, Sara Comini, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2022
Increased <i>bla</i><sub>KPC</sub> Copy Number and OmpK35 and OmpK36 Porins Disruption Mediated Resistance to Imipenem/Relebactam and Meropenem/Vaborbactam in a KPC-Producing Klebsiella pneumoniae Clinical IsolatePaolo Gaibani, Gabriele Bianco, Stefano Amadesi, et al.
Journal of Chemotherapy (Florence, Italy)|April 12, 2021
Looking beyond ceftazidime-avibactam resistance in KPC-producing <i>Klebsiella pneumoniae</i>: <i>in vitro</i> activity of the novel meropenem-vaborbactam in combination with the old fosfomycinMatteo Boattini, Gabriele Bianco, Marco Iannaccone, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 11, 2025
In vitro activity and resistance mechanisms of novel antimicrobial agents against metallo-β-lactamase producersMatteo Boattini, Paolo Gaibani, Sara Comini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 31, 2021
In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effectsGabriele Bianco, Matteo Boattini, Sara Comini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 21, 2022
Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 eraGabriele Bianco, Matteo Boattini, Sara Comini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 18, 2021
Fast-track identification of CTX-M-extended-spectrum-β-lactamase- and carbapenemase-producing Enterobacterales in bloodstream infections: implications on the likelihood of deduction of antibiotic susceptibility in emergency and internal medicine departmentsMatteo Boattini, Gabriele Bianco, Marco Iannaccone, et al.
Pathogens (Basel, Switzerland)|June 26, 2024
Complete Genome Sequence of a <i>Klebsiella pneumoniae</i> Strain Carrying Novel Variant <i>bla</i><sub>KPC-203</sub>, Cross-Resistant to Ceftazidime/Avibactam and Cefiderocol, but Susceptible to Carbapenems, Isolated in Italy, 2023Stefano Amadesi, Gabriele Bianco, Benedetta Secci, et al.
Microorganisms|January 21, 2023
MALDI-TOF MS-Based Approaches for Direct Identification of Gram-Negative Bacteria and <i>Bla</i><sub>KPC</sub>-Carrying Plasmid Detection from Blood Cultures: A Three-Year Single-Centre Study and Proposal of a Diagnostic AlgorithmGabriele Bianco, Sara Comini, Matteo Boattini, et al.
Pageof 9